Nuclear Medicine and Molecular Imaging in Nodal Staging and Surveillance of Ocular Melanoma: Case Reports and Review of the Literature

J Nucl Med Technol. 2021 Sep;49(3):275-280. doi: 10.2967/jnmt.120.260539. Epub 2021 Apr 5.

Abstract

Ocular melanoma (OM) is a rare noncutaneous malignancy and consists of 2 different subtypes based on the anatomic location in the eye: uveal melanoma and conjunctival melanoma. Like cutaneous melanoma, OM benefits from nuclear medicine and molecular imaging in nodal staging and clinical management. Through the illustration of 2 distinctive cases, we aim to demonstrate the complementary roles of standard lymphoscintigraphy, advanced SPECT/CT, 18F-FDG PET/CT, and 18F-FDG PET/MRI in accurate nodal staging and surveillance of OM. We also review the epidemiology, existing staging guidelines, and management of uveal melanoma and conjunctival melanoma.

Keywords: 18F-FDG/PET; SPECT; conjunctival melanoma; lymphoscintigraphy; uveal melanoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Fluorodeoxyglucose F18
  • Humans
  • Melanoma* / diagnostic imaging
  • Molecular Imaging
  • Neoplasm Staging
  • Nuclear Medicine*
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals
  • Skin Neoplasms*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18